DCN and neoplasm: Identification of the signaling pathways and mechanisms regulating TGFβ1-induced decorin down-regulation in CAF/MF in vitro and in vivo will provide a rationale for new therapeutic options aimed to neutralize the oncogenic role of TGFβ1 as a repressor of the decorin tumor suppressive functions.